The Nomination Committee´s proposal for new Board of Directors to the Annual General Meeting 2018
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces the Nomination Committee’s proposal for a new Board of Directors to the Annual General Meeting 2018. The Nomination Committee 2017-2018 is composed of representatives for the company’s three largest shareholders at the end of the third quarter of 2017, who have accepted to be part of the Nomination Committee, and the Chairman of the Board. The Nomination Committee 2017-2018 members have been: · Maria Rengefors, Chairman of the Nomination Committee, representing Nordea Fonder · Bo Öberg, representing the class A